查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825780

2025年全球切片檢查市場報告

Kidney Biopsy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年切片檢查市場規模將強勁成長，到2029年將達到27.5億美元，複合年成長率為5.0%。預測期內的成長可歸因於腎臟疾病盛行率的上升、醫療保健支出的增加、早期診斷意識的增強、老年人口的擴大、微創手術需求的增加以及研究活動的活性化。預測期內的主要趨勢包括切片檢查技術的進步、微創手術的普及、成像技術的進步、人工智慧的整合以提高準確性以及切片檢查設備的創新。

預測的五年成長率為5.0%，較我們先前對該市場的預測略有下降0.4%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致以色列和德國開發的自動切片檢查槍和腎臟病理人工智慧 (AI) 分析系統價格上漲，從而擾亂美國的腎臟病美國實踐，導致腎臟疾病診斷延誤和診斷程序成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，貿易摩擦的影響可能更為廣泛。

腎癌發病率的不斷上升推動了切片檢查市場的成長。腎癌是指異常腎細胞不受控制地生長，其發生率受生活方式改變、環境毒素和診斷方法改進等因素的影響，導致檢出率不斷提高。切片檢查在腎癌的診斷和治療中發揮關鍵作用，它可以確認癌細胞的存在、確定癌症分期、指導治療策略、監測治療反應並提供預後資訊。例如，英國癌症研究中心預測，腎癌新病例數將從2023年的約16,300例增加到2025年的約21,900例，凸顯了對研究服務日益成長的需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腎臟切片檢查：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球切片檢查市場：成長率分析
  • 全球切片檢查市場表現：規模與成長，2019-2024
  • 全球切片檢查市場預測：規模與成長，2024-2029，2034
  • 全球切片檢查：總目標市場（TAM）

第6章 市場細分

  • 全球切片檢查市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 切片檢查
  • 手術切片檢查
  • 全球切片檢查市場（依適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 腎衰竭
  • 腎臟移植
  • 血尿
  • 蛋白尿
  • 全球切片檢查市場最終使用者、績效及預測（2019-2024、2024-2029、2034）
  • 醫院和診所
  • 泌尿系統中心
  • 三級醫療中心
  • 其他
  • 全球切片檢查切片市場：經皮細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 超音波引導下切片檢查
  • CT引導下切片檢查
  • MRI導引下切片檢查
  • 全球切片檢查切片市場：外科切片檢查細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 開放性腎臟切片檢查
  • 腹腔鏡切片檢查

第7章 區域和國家分析

  • 全球切片檢查市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球切片檢查市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 切片檢查切片市場：競爭格局
  • 切片檢查切片市場：公司簡介
    • Cardinal Health
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • AstraZeneca

第31章：其他領先和創新企業

  • Medtronic
  • Siemens Healthcare Private Limited
  • Becton, Dickinson and Company
  • Stryker Healthcare
  • Baxter International Inc.
  • Boston Scientific Corporation
  • F. Hoffmann-La Roche Ltd.
  • Zimmer Biomet
  • Agilent Technologies Inc.
  • Olympus Corporation
  • Hitachi High-Tech Corporation
  • Beckman Coulter Inc.
  • B. Braun
  • Sysmex Corporation
  • Cook Medical

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年切片檢查市場：提供新機會的國家
  • 2029年切片檢查市場：細分領域帶來新機會
  • 2029年切片檢查市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30537u

A kidney biopsy, also referred to as a renal biopsy, is a medical procedure where a small sample of kidney tissue is extracted for microscopic analysis. This procedure is commonly conducted to diagnose kidney conditions, evaluate the severity of existing kidney diseases, or monitor treatment effectiveness. It plays a crucial role in identifying diverse kidney disorders such as glomerulonephritis, interstitial nephritis, and nephrotic syndrome, offering insights into the underlying causes of kidney dysfunction.

The primary types of kidney biopsy include percutaneous biopsy and surgical biopsy. Percutaneous biopsy involves inserting a needle through the skin to obtain tissue samples from the kidney for examination. This method is utilized in various clinical settings including cases of kidney failure, kidney transplantation, hematuria, and proteinuria. It is employed by hospitals, clinics, urology centers, tertiary care centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The kidney biopsy market research report is one of a series of new reports from The Business Research Company that provides kidney biopsy market statistics, including the kidney biopsy industry global market size, regional shares, competitors with kidney biopsy market share, detailed kidney biopsy market segments, market trends, and opportunities, and any further data you may need to thrive in the kidney biopsy industry. These kidney biopsy market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The kidney biopsy market size has grown strongly in recent years. It will grow from $2.14 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased chronic kidney diseases, rise in awareness about early diagnosis, surge in geriatric population, expansion of healthcare infrastructure, enhanced government initiatives for kidney disease management, and rise in awareness of kidney health.

The kidney biopsy market size is expected to see strong growth in the next few years. It will grow to $2.75 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing prevalence of kidney diseases, rising healthcare expenditure, growing awareness about early diagnosis, expanding geriatric population, rising demand for minimally invasive procedures, and increasing research activities. Major trends in the forecast period include technological advancements in biopsy techniques, adoption of minimally invasive procedures, advancements in imaging technologies, integration of artificial intelligence for better precision, and technological innovations in biopsy devices.

The forecast of 5.0% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. nephrology practices by inflating prices of automated biopsy guns and renal pathology Artificial intelligence(AI) analysis systems developed in Israel and Germany, resulting in delayed renal disease diagnosis and higher diagnostic procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of renal cancer is poised to drive growth in the kidney biopsy market. Renal cancer involves the unchecked proliferation of abnormal kidney cells, influenced by factors such as lifestyle changes, environmental toxins, and improved diagnostic methods leading to higher detection rates. Kidney biopsies play a crucial role in diagnosing and managing renal cancer by confirming the presence of cancerous cells, determining cancer stage, guiding treatment strategies, monitoring treatment response, and providing prognostic insights. For example, Cancer Research UK projects an anticipated rise in new kidney cancer cases from approximately 16,300 in 2023 to about 21,900 by 2025, underscoring the escalating demand for kidney biopsy services.

Leading companies in the kidney biopsy market are innovating by integrating artificial intelligence (AI) to enhance diagnostic precision, streamline procedures, and optimize patient outcomes. AI technology improves kidney biopsy analysis by enhancing image interpretation, supporting diagnostic decisions, assisting in treatment planning, offering predictive analytics, and advancing research in kidney diseases. For instance, Aiosyn, a Netherlands-based software firm, introduced the NephroPath platform in March 2024. This platform utilizes computational pathology algorithms to analyze histological biomarkers in kidney biopsies, including tissue type identification, measurement of interstitial fibrosis, and precise quantification and evaluation of glomeruli. Such AI-driven analysis ensures consistent, detailed, and reproducible assessment of renal pathology biomarkers, overcoming limitations associated with traditional scoring methods and reducing observer subjectivity.

In October 2022, Halma plc, a UK-based technology company, acquired IZI Medical Products for $176 million. This strategic acquisition enhances Halma plc's footprint in the kidney biopsy sector by integrating IZI Medical's advanced core biopsy devices. These devices are utilized across various anatomical sites, including kidneys, thyroid, intra-abdominal areas, and liver, aimed at improving the safety, accuracy, and efficacy of biopsy procedures. This acquisition underscores Halma plc's commitment to advancing biopsy technologies to benefit both patients and healthcare providers.

Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

North America was the largest region in the kidney biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the kidney biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The kidney biopsy market consists of revenues earned by entities by providing services such as diagnostic biopsy, therapeutic biopsy, post-biopsy care and monitoring, and pathological analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney biopsy market also includes sales of biopsy needles, biopsy guns, biopsy trays and kits, and biopsy specimen containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kidney Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kidney biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for kidney biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The kidney biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Percutaneous Biopsy; Surgical Biopsy
  • 2) By Indication: Kidney Failure; Kidney Transplant; Hematuria; Proteinuria
  • 3) By End-User: Hospitals And Clinics; Urology Centers; Tertiary Care Centers; Other End-Users
  • Subsegments:
  • 1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy; CT-Guided Biopsy; MRI-Guided Biopsy
  • 2) By Surgical Biopsy: Open Kidney Biopsy; Laparoscopic Kidney Biopsy
  • Companies Mentioned: Cardinal Health; Pfizer Inc.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; AstraZeneca; Medtronic; Siemens Healthcare Private Limited; Becton, Dickinson and Company; Stryker Healthcare; Baxter International Inc.; Boston Scientific Corporation; F. Hoffmann-La Roche Ltd.; Zimmer Biomet; Agilent Technologies Inc.; Olympus Corporation; Hitachi High-Tech Corporation; Beckman Coulter Inc.; B. Braun; Sysmex Corporation; Cook Medical; Bio-Rad Laboratories Inc.; Integra LifeSciences Corporation; Merit Medical Systems; Leica Biosystems Nussloch GmbH; Argon Medical Devices Inc.; BioGenex
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Kidney Biopsy Market Characteristics

3. Kidney Biopsy Market Trends And Strategies

4. Kidney Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Kidney Biopsy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Kidney Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Kidney Biopsy Market Growth Rate Analysis
  • 5.4. Global Kidney Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Kidney Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Kidney Biopsy Total Addressable Market (TAM)

6. Kidney Biopsy Market Segmentation

  • 6.1. Global Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Percutaneous Biopsy
  • Surgical Biopsy
  • 6.2. Global Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Failure
  • Kidney Transplant
  • Hematuria
  • Proteinuria
  • 6.3. Global Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Urology Centers
  • Tertiary Care Centers
  • Other End-Users
  • 6.4. Global Kidney Biopsy Market, Sub-Segmentation Of Percutaneous Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound-Guided Biopsy
  • CT-Guided Biopsy
  • MRI-Guided Biopsy
  • 6.5. Global Kidney Biopsy Market, Sub-Segmentation Of Surgical Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Kidney Biopsy
  • Laparoscopic Kidney Biopsy

7. Kidney Biopsy Market Regional And Country Analysis

  • 7.1. Global Kidney Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Kidney Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Kidney Biopsy Market

  • 8.1. Asia-Pacific Kidney Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Kidney Biopsy Market

  • 9.1. China Kidney Biopsy Market Overview
  • 9.2. China Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Kidney Biopsy Market

  • 10.1. India Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Kidney Biopsy Market

  • 11.1. Japan Kidney Biopsy Market Overview
  • 11.2. Japan Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Kidney Biopsy Market

  • 12.1. Australia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Kidney Biopsy Market

  • 13.1. Indonesia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Kidney Biopsy Market

  • 14.1. South Korea Kidney Biopsy Market Overview
  • 14.2. South Korea Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Kidney Biopsy Market

  • 15.1. Western Europe Kidney Biopsy Market Overview
  • 15.2. Western Europe Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Kidney Biopsy Market

  • 16.1. UK Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Kidney Biopsy Market

  • 17.1. Germany Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Kidney Biopsy Market

  • 18.1. France Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Kidney Biopsy Market

  • 19.1. Italy Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Kidney Biopsy Market

  • 20.1. Spain Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Kidney Biopsy Market

  • 21.1. Eastern Europe Kidney Biopsy Market Overview
  • 21.2. Eastern Europe Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Kidney Biopsy Market

  • 22.1. Russia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Kidney Biopsy Market

  • 23.1. North America Kidney Biopsy Market Overview
  • 23.2. North America Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Kidney Biopsy Market

  • 24.1. USA Kidney Biopsy Market Overview
  • 24.2. USA Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Kidney Biopsy Market

  • 25.1. Canada Kidney Biopsy Market Overview
  • 25.2. Canada Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Kidney Biopsy Market

  • 26.1. South America Kidney Biopsy Market Overview
  • 26.2. South America Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Kidney Biopsy Market

  • 27.1. Brazil Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Kidney Biopsy Market

  • 28.1. Middle East Kidney Biopsy Market Overview
  • 28.2. Middle East Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Kidney Biopsy Market

  • 29.1. Africa Kidney Biopsy Market Overview
  • 29.2. Africa Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Kidney Biopsy Market Competitive Landscape And Company Profiles

  • 30.1. Kidney Biopsy Market Competitive Landscape
  • 30.2. Kidney Biopsy Market Company Profiles
    • 30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis

31. Kidney Biopsy Market Other Major And Innovative Companies

  • 31.1. Medtronic
  • 31.2. Siemens Healthcare Private Limited
  • 31.3. Becton, Dickinson and Company
  • 31.4. Stryker Healthcare
  • 31.5. Baxter International Inc.
  • 31.6. Boston Scientific Corporation
  • 31.7. F. Hoffmann-La Roche Ltd.
  • 31.8. Zimmer Biomet
  • 31.9. Agilent Technologies Inc.
  • 31.10. Olympus Corporation
  • 31.11. Hitachi High-Tech Corporation
  • 31.12. Beckman Coulter Inc.
  • 31.13. B. Braun
  • 31.14. Sysmex Corporation
  • 31.15. Cook Medical

32. Global Kidney Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Kidney Biopsy Market

34. Recent Developments In The Kidney Biopsy Market

35. Kidney Biopsy Market High Potential Countries, Segments and Strategies

  • 35.1 Kidney Biopsy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Kidney Biopsy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Kidney Biopsy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer